OTC Healthcare in Belgium to 2011

Published by: Datamonitor

Published: Jul. 31, 2008 - 190 Pages

Table of Contents

Chapter 1 EXECUTIVE SUMMARY

Summary Market Level - OTC Healthcare

Summary category level - Analgesics

Summary category level - Cough and Cold Preparations

Summary category level - Traditional Medicines

Summary category level - First Aid Kits

Summary category level - Indigestion Preparations

Summary category level - Vitamins and Minerals

Summary category level - Plasters & Bandages

Summary category level - Medicated Skin Products

Summary category level - Other OTC Healthcare Products

Summary category level - Topical OTC Medicines

Chapter 2 INTRODUCTION

What is this report about?

How to use this report

Market Definition

Chapter 3 MARKET OVERVIEW

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 4 LEADING COMPANY PROFILES

Omega Pharma NV

Novartis AG

Chapter 5 CATEGORY ANALYSIS - ANALGESICS

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES

Value Analysis, 2001-2006

Value Analysis, 2006-2011

Value Analysis, US$ 2001-2006

Value Analysis, US$ 2006-2011

Company and Brand Share Analysis

Expenditure & consumption per capita

Chapter 15 COUNTRY COMPARISON

Value

Market Share

Chapter 16 NEW PRODUCT DEVELOPMENT

Product launches over time

Recent product launches

Chapter 17 BELGIUM SOCIOECONOMIC PROFILE

Country Overview

Key Facts

Political Overview

Belgium Economic Overview

Chapter 18 BELGIUM MACROECONOMIC PROFILE

Macroeconomic Indicators

Chapter 19 RESEARCH METHODOLOGY

Methodology overview

Secondary research

Market modelling

Primary research

Data finalisation

Ongoing research

Chapter 20 APPENDIX

Future readings

How to contact experts in your industry

LIST OF FIGURES

Figure 1: Belgium OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 2: Belgium OTC Healthcare category growth comparison, by value, 2001-2011

Figure 3: Belgium OTC Healthcare company share, by value, 2005-2006 (%)

Figure 4: Belgium Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 5: Belgium Analgesics category growth comparison, by value, 2001-2011

Figure 6: Belgium Analgesics company share, by value, 2005-2006 (%)

Figure 7: Belgium Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 8: Belgium Cough and Cold Preparations category growth comparison, by value, 2001-2011

Figure 9: Belgium Cough and Cold Preparations company share, by value, 2005-2006 (%)

Figure 10: Belgium Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 11: Belgium Traditional Medicines company share, by value, 2005-2006 (%)

Figure 12: Belgium First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 13: Belgium First Aid Kits company share, by value, 2005-2006 (%)

Figure 14: Belgium Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 15: Belgium Indigestion Preparations category growth comparison, by value, 2001-2011

Figure 16: Belgium Indigestion Preparations company share, by value, 2005-2006 (%)

Figure 17: Belgium Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 18: Belgium Vitamins and Minerals category growth comparison, by value, 2001-2011

Figure 19: Belgium Vitamins and Minerals company share, by value, 2005-2006 (%)

Figure 20: Belgium Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 21: Belgium Plasters & Bandages category growth comparison, by value, 2001-2011

Figure 22: Belgium Plasters & Bandages company share, by value, 2005-2006 (%)

Figure 23: Belgium Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 24: Belgium Medicated Skin Products category growth comparison, by value, 2001-2011

Figure 25: Belgium Medicated Skin Products company share, by value, 2005-2006 (%)

Figure 26: Belgium Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 27: Belgium Other OTC Healthcare Products category growth comparison, by value, 2001-2011

Figure 28: Belgium Other OTC Healthcare Products company share, by value, 2005-2006 (%)

Figure 29: Belgium Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)

Figure 30: Belgium Topical OTC Medicines category growth comparison, by value, 2001-2011

Figure 31: Belgium Topical OTC Medicines company share, by value, 2005-2006 (%)

Figure 32: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries

Figure 33: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)

Figure 34: Map of Belgium

Figure 35: Annual data review process

LIST OF TABLES

Table 1: OTC Healthcare category definitions

Table 2: Belgium OTC Healthcare value, 2001-2006 (EUR m, nominal prices)

Table 3: Belgium OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices)

Table 4: Belgium OTC Healthcare value, 2001-2006 (US$ m nominal prices)

Table 5: Belgium OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)

Table 6: Belgium OTC Healthcare brand share, by value, 2005-2006 (%)

Table 7: Belgium OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices)

Table 8: Belgium OTC Healthcare company share by value, 2005-2006 (%)

Table 9: Belgium OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices)

Table 10: Belgium OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 11: Belgium OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 12: Belgium OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)

Table 13: Belgium OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 14: Omega Pharma NV Key Facts

Table 15: Novartis AG Key Facts

Table 16: Belgium Analgesics value, 2001-2006 (EUR m, nominal prices)

Table 17: Belgium Analgesics value forecast, 2006-2011 (EUR m, nominal prices)

Table 18: Belgium Analgesics value, 2001-2006 (US$ m nominal prices)

Table 19: Belgium Analgesics value forecast, 2006-2011 (US$ m nominal prices)

Table 20: Belgium Analgesics brand share, by value, 2005-2006 (%)

Table 21: Belgium Analgesics value, by brand 2005-2006 (EUR m nominal prices)

Table 22: Belgium Analgesics company share by value, 2005-2006 (%)

Table 23: Belgium Analgesics value, by company, 2005-2006 (EUR m nominal prices)

Table 24: Belgium Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 25: Belgium Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 26: Belgium Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)

Table 27: Belgium Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 28: Belgium Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices)

Table 29: Belgium Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices)

Table 30: Belgium Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)

Table 31: Belgium Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)

Table 32: Belgium Cough and Cold Preparations brand share, by value, 2005-2006 (%)

Table 33: Belgium Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices)

Table 34: Belgium Cough and Cold Preparations company share by value, 2005-2006 (%)

Table 35: Belgium Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices)

Table 36: Belgium Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 37: Belgium Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 38: Belgium Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)

Table 39: Belgium Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 40: Belgium Traditional Medicines value, 2001-2006 (EUR m, nominal prices)

Table 41: Belgium Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices)

Table 42: Belgium Traditional Medicines value, 2001-2006 (US$ m nominal prices)

Table 43: Belgium Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)

Table 44: Belgium Traditional Medicines brand share, by value, 2005-2006 (%)

Table 45: Belgium Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices)

Table 46: Belgium Traditional Medicines company share by value, 2005-2006 (%)

Table 47: Belgium Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices)

Table 48: Belgium Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 49: Belgium Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 50: Belgium Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)

Table 51: Belgium Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 52: Belgium First Aid Kits value, 2001-2006 (EUR m, nominal prices)

Table 53: Belgium First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices)

Table 54: Belgium First Aid Kits value, 2001-2006 (US$ m nominal prices)

Table 55: Belgium First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)

Table 56: Belgium First Aid Kits brand share, by value, 2005-2006 (%)

Table 57: Belgium First Aid Kits value, by brand 2005-2006 (EUR m nominal prices)

Table 58: Belgium First Aid Kits company share by value, 2005-2006 (%)

Table 59: Belgium First Aid Kits value, by company, 2005-2006 (EUR m nominal prices)

Table 60: Belgium First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 61: Belgium First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 62: Belgium First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)

Table 63: Belgium First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 64: Belgium Indigestion Preparations value, 2001-2006 (EUR m, nominal prices)

Table 65: Belgium Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices)

Table 66: Belgium Indigestion Preparations value, 2001-2006 (US$ m nominal prices)

Table 67: Belgium Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)

Table 68: Belgium Indigestion Preparations brand share, by value, 2005-2006 (%)

Table 69: Belgium Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices)

Table 70: Belgium Indigestion Preparations company share by value, 2005-2006 (%)

Table 71: Belgium Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices)

Table 72: Belgium Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 73: Belgium Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 74: Belgium Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)

Table 75: Belgium Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 76: Belgium Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices)

Table 77: Belgium Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices)

Table 78: Belgium Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)

Table 79: Belgium Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)

Table 80: Belgium Vitamins and Minerals brand share, by value, 2005-2006 (%)

Table 81: Belgium Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices)

Table 82: Belgium Vitamins and Minerals company share by value, 2005-2006 (%)

Table 83: Belgium Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices)

Table 84: Belgium Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 85: Belgium Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 86: Belgium Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)

Table 87: Belgium Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 88: Belgium Plasters & Bandages value, 2001-2006 (EUR m, nominal prices)

Table 89: Belgium Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices)

Table 90: Belgium Plasters & Bandages value, 2001-2006 (US$ m nominal prices)

Table 91: Belgium Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)

Table 92: Belgium Plasters & Bandages brand share, by value, 2005-2006 (%)

Table 93: Belgium Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices)

Table 94: Belgium Plasters & Bandages company share by value, 2005-2006 (%)

Table 95: Belgium Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices)

Table 96: Belgium Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 97: Belgium Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 98: Belgium Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)

Table 99: Belgium Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 100: Belgium Medicated Skin Products value, 2001-2006 (EUR m, nominal prices)

Table 101: Belgium Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices)

Table 102: Belgium Medicated Skin Products value, 2001-2006 (US$ m nominal prices)

Table 103: Belgium Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)

Table 104: Belgium Medicated Skin Products brand share, by value, 2005-2006 (%)

Table 105: Belgium Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices)

Table 106: Belgium Medicated Skin Products company share by value, 2005-2006 (%)

Table 107: Belgium Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices)

Table 108: Belgium Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 109: Belgium Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 110: Belgium Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)

Table 111: Belgium Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 112: Belgium Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices)

Table 113: Belgium Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices)

Table 114: Belgium Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)

Table 115: Belgium Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)

Table 116: Belgium Other OTC Healthcare Products brand share, by value, 2005-2006 (%)

Table 117: Belgium Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices)

Table 118: Belgium Other OTC Healthcare Products company share by value, 2005-2006 (%)

Table 119: Belgium Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices)

Table 120: Belgium Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 121: Belgium Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 122: Belgium Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)

Table 123: Belgium Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 124: Belgium Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices)

Table 125: Belgium Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices)

Table 126: Belgium Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)

Table 127: Belgium Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)

Table 128: Belgium Topical OTC Medicines brand share, by value, 2005-2006 (%)

Table 129: Belgium Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices)

Table 130: Belgium Topical OTC Medicines company share by value, 2005-2006 (%)

Table 131: Belgium Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices)

Table 132: Belgium Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)

Table 133: Belgium Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)

Table 134: Belgium Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)

Table 135: Belgium Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)

Table 136: Global OTC Healthcare market value, 2006

Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries

Table 138: Leading players - Top 5 countries

Table 139: Belgium OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006

Table 140: Belgium OTC Healthcare new product launches (reports), by flavor and fragrances 2006

Table 141: Belgium OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006

Table 142: Belgium OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006

Table 143: Belgium OTC Healthcare new product launches (reports) - Recent 5 launches

Table 144: Belgium Key Facts

Table 145: Belgium population, by age group, 2000-2005 (millions)

Table 146: Belgium population forecast, by age group, 2005-2010 (millions)

Table 147: Belgium population, by gender, 2000-2005 (millions)

Table 148: Belgium population forecast, by gender, 2005-2010 (millions)

Table 149: Belgium real GDP, 2000-2005 (EUR bn, 2005 prices)

Table 150: Belgium real GDP forecast, 2005-2010 (EUR bn, 2005 prices)

Table 151: Belgium nominal GDP, 2000-2005 (EUR bn, nominal prices)

Table 152: Belgium real GDP, 2000-2005 (US$ bn, 2005 prices)

Table 153: Belgium real GDP forecast, 2005-2010 (US$ bn, 2005 prices)

Table 154: Belgium consumer price index, 2000-2005 (2000=100)

Table 155: Belgium consumer price index, 2005-2010 (2000=100)

Table 156: Belgium exchange rate, 2000-2005

Abstract

• Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
• Provides market value, volume, expenditure and consumption data by market, segment and subsegment
• Includes company and brand share data by categories

• Discover the major quantitative trends affecting the OTC Healthcare markets
• Understand consumers' consumption and expenditure patterns
• Understand the future direction of the market with reliable historical data and full five year forecasting

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.